The envelope proteins from SARS-CoV-2 and SARS-CoV potently reduce the infectivity of human immunodeficiency virus type 1 (HIV-1)Wyatt Henke, Edward B. Stephens|Retrovirology|2022Cited by 4
The Envelope Protein of SARS-CoV-2 Inhibits Viral Protein Synthesis and Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)Wyatt Henke, Edward B. Stephens|bioRxiv (Cold Spring Harbor Laboratory)|2022Cited by 2
A Viroporin from SARS-CoV-2 Reduces the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)Wyatt Henke, Edward B. Stephens|Research Square|2022Cited by 0
The Envelope Proteins from SARS-CoV-2 and SARS-CoV Potently Reduce the Infectivity of Human Immunodeficiency Virus type 1 (HIV-1)Wyatt Henke, Edward B. Stephens|Research Square|2022Cited by 0